欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1827/001
药品名称Valganciclovir Teva
活性成分
    • Valganciclovir hydrochloride 450.0 mg
剂型Film-coated tablet
上市许可持有人Teva Sweden AB
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Valganciclovir Hydrochloride 450 mg Film-coated Tablets
    • Germany (DE)
      TeValgan
    • Denmark (DK)
    • Netherlands (NL)
    • Austria (AT)
      Valganciclovir ratiopharm 450 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Norway (NO)
      Valganciclovir Teva
    • Czechia (CZ)
      Valganciclovir - Teva 450 mg
    • Slovenia (SI)
      GANAXA 450 mg filmsko obložene tablete
许可日期2014/01/20
最近更新日期2025/09/05
药物ATC编码
    • J05AB14 valganciclovir
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase